Japan's Hisamitsu Pharmaceutical will buy Noven Pharmaceuticals for $428 million as it looks to boost its presence in the U.S.
WSJ.com: US Business, Wall Street Journal: Business
Tue, 07/14/2009 - 7:55am
Japan's Hisamitsu Pharmaceutical will buy Noven Pharmaceuticals for $428 million as it looks to boost its presence in the U.S.